Institutional funding access of up to $750 million after your listing. An equity line of credit (ELOC) gives a newly listed company the right — but not the obligation — to sell shares to an institutional investor over time, at prices tied to the prevailing market.
Why an equity line
- Flexible. Draw capital when you need it, in the amounts you choose, rather than raising everything at once.
- Cost-effective. Percentage costs are lower than bond issuance or a firm-commitment equity offering.
- Market-priced. Sales occur at prices referenced to the market at the time of each draw, not a discount fixed months in advance.
- Non-dilutive until used. No shares are issued, and no dilution occurs, until the company elects to draw.
What the engagement covers
- Structuring the facility and negotiating terms with institutional providers
- Registration statement covering the resale shares, prepared and EDGARized by the same team
- Draw strategy aligned with trading volume and disclosure windows
- Ongoing compliance — prospectus supplements and Exchange Act reporting tied to the facility
Discuss a facility for your post-listing capital plan.